Literature DB >> 10604481

Different platelet aggregability during mental stress in two stages of essential hypertension.

F Tomoda1, M Takata, S Kagitani, H Kinuno, K Yasumoto, S Tomita, H Inoue.   

Abstract

To determine whether platelet response to mental stress is altered in essential hypertension, platelet aggregability and plasma beta-thromboglobulin were determined in 24 patients with essential hypertension (11 patients with World Health Organization (WHO) stage I and 13 patients with stage II) and 14 normotensive controls before and after a 10-min arithmetic stress (serial subtraction of 7 from 1000). In normotensive subjects, arithmetic stress did not affect primary aggregations to 1.0 micromol/L adenosine diphosphate (ADP) and to 2.5 micromol/L 5-hydroxytryptamine (5-HT), ADP threshold for biphasic aggregation and plasma beta-thromboglobulin level. In hypertensive patients with WHO stage I, these parameters were similar to those in normotensives before arithmetic stress, but the arithmetic stress test significantly increased primary aggregation to reagents and beta-thromboglobulin level, and decreased threshold of ADP for biphasic aggregation. In WHO stage II patients, platelet aggregability to reagents and beta-thromboglobulin level were already enhanced as compared with WHO stage I patients and normotensive subjects before arithmetic stress. However, the stress-induced changes in platelet function were less pronounced in WHO stage II patients compared with stage I patients. In conclusion, platelet aggregability and proaggregatory effect of mental stress differed depending on the severity of hypertension in patients with essential hypertension; the transient activation of platelet function during stress with no enhancement under the resting condition in the early phase of hypertension and the continuous activation of platelet function in the advanced phase with hypertensive organ damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604481     DOI: 10.1016/s0895-7061(99)00131-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?

Authors:  Daniel Preckel; Roland von Känel
Journal:  Heartdrug       Date:  2004

Review 2.  Influence of mental stress on platelet bioactivity.

Authors:  Pia Koudouovoh-Tripp; Barbara Sperner-Unterweger
Journal:  World J Psychiatry       Date:  2012-12-22

3.  Incidence and predictors of stroke during the index event in an ethnically diverse Takotsubo cardiomyopathy population.

Authors:  A Dias; E Franco; S Janzer; Nikoloz Koshkelashvili; V Bhalla; Manolo Rubio; Sarah Amanullah; Kathy Hebert; Vincent M Figueredo
Journal:  Funct Neurol       Date:  2016 Jul-Sep

4.  Platelet function in Takotsubo cardiomyopathy.

Authors:  Iván J Núñez-Gil; Esther Bernardo; Gisela Feltes; Javier Escaned; Hernán D Mejía-Rentería; José Alberto De Agustín; David Vivas; Luis Nombela-Franco; Pilar Jiménez-Quevedo; Carlos Macaya; Antonio Fernández-Ortiz
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

5.  Antiplatelet therapy in Takotsubo cardiomyopathy: does it improve cardiovascular outcomes during index event?

Authors:  Andre Dias; Emiliana Franco; Nikoloz Koshkelashvili; Vikas Bhalla; Gregg S Pressman; Kathy Hebert; Vincent M Figueredo
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

6.  Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome.

Authors:  Hiroko Sugimori; Fumihiro Tomoda; Tsutomu Koike; Hiroyuki Kinuno; Hiroko Kurosaki; Toshitaka Masutani; Hiroshi Inoue
Journal:  Int J Hypertens       Date:  2012-04-18       Impact factor: 2.420

7.  Stress Enhances Proinflammatory Platelet Activity: the Impact of Acute and Chronic Mental Stress.

Authors:  Pia Koudouovoh-Tripp; Katharina Hüfner; Jonas Egeter; Christina Kandler; Johannes M Giesinger; Sieghart Sopper; Christian Humpel; Barbara Sperner-Unterweger
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-05       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.